Versant Capital Management »

Cytek Biosciences shares owned by Versant Capital Management

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.7k 1.0k 5.54
2023-09-30 $1.6k 286 5.52

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Vanguard Emerging Markets Government Bond Etf Etf (VWOB)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Ishares S&p Global Energy Etf (IXC)
Microsoft Stock (MSFT)
Vaneck Gold Miners Etf Etf (GDX)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Vanguard Total Stk Mkt Etf (VTI)
Exxon Mobil Corp Stock (XOM)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Spdr Gold Minishares Trust Etf (GLDM)
Dimensional Us Marketwide Value Etf Etf (DFUV)

View all positions for Versant Capital Management

Top funds holding Cytek Biosciences

BlackRock
BlackRock
Vanguard Group
Brown Capital Management
Hillhouse Capital Advisors
State Street Corporation
Geode Capital Management
New York State Common Retirement Fund
Dimensional Fund Advisors
Goldman Sachs Group
Northern Trust
Charles Schwab Investment Management
Morgan Stanley
Bank of New York Mellon
Connor, Clark & Lunn Investment Management

View all funds holding Cytek Biosciences